Zobrazeno 101 - 110
of 656
pro vyhledávání: ''
Autor:
Ridvan Firestone, Soo Cheng, Neil Pearce, Lis Ellison-Loschmann, Mona Jeffreys, Ate Moala, Michelle Gray, Fiona McKenzie
Publikováno v:
Cancer Causes & Control
PURPOSE: To investigate whether the relationships between established risk factors and breast cancer risk differ between three ethnic groups in New Zealand, namely Māori, Pacific, and non-Māori/non-Pacific women. METHODS: The study is a multi-ethni
Autor:
Kathy Schilling, Deepa Narayanan, Judith E. Kalinyak, Juliette The, Maria Victoria Velasquez, Simone Kahn, Matthew Saady, Ravinder Mahal, Larraine Chrystal
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose The objective of this study was to compare the performance characteristics of 18F-fluorodeoxyglucose (FDG) positron emission mammography (PEM) with breast magnetic resonance imaging (MRI) as a presurgical imaging and planning option for index
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Background and purpose Breast carcinoma is the most common cancer in female patients with a propensity for recurrence and metastases. The accuracy of ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), scintimammography (SMM)
Autor:
Kazuo Ishizuna, Masafumi Kurosumi, Toshihiro Kai, Hirofumi Yamada, Katsuhiko Okubo, Kei Kimizuka, Satoshi Hata, Tsuyoshi Saito, Kenichi Inoue, Takashi Sakurai
Publikováno v:
Breast Cancer Research and Treatment
No clinical evidence on the efficacy and safety of eribulin monotherapy has been obtained by a prospective clinical study in patients with metastatic breast cancer (MBC) who had well-defined taxane resistance. The present Phase II, multicenter, singl
Publikováno v:
Clinical & Experimental Metastasis
Germline mutations affecting the retinoblastoma gene (RB1) predispose to inherited retinoblastomas but also other malignancies, including breast cancer. While somatic RB1 mutations have been detected in different malignancies, information about the p
Autor:
Alex A. Adjei, Paolo Andrea Zucali, Julie Means-Powell, Maria Lamar, Brian Schwartz, Armando Santoro, Laura W. Goff, Robert E. Martell, Ronald E. Savage, Matteo Simonelli, Jeffrey A. Sosman, Grace K. Dy, Wen Wee Ma, Muhammad Wasif Saif, Feng Chai, Igor Puzanov
Publikováno v:
Investigational New Drugs
SummaryPurpose This phase I study evaluated the safety, tolerability, maximum tolerated dose (MTD), and recommended phase II dose (RP2D) of tivantinib combined with sorafenib in patients with advanced solid tumors. Materials and Methods A standard 3
Autor:
Linda K. Han, Mark B. Faries, Charles E. Cox, Kenneth B. Deck, Anne M. Wallace, David R. Vera, Dennis King, Eli Avisar, Helen Krontiras, Lori Christman, Schlomo Schneebaum, Carl K. Hoh, Nathan Hall, Thomas G. Frazier, Stephen P. Povoski, Karl K. Limmer
Publikováno v:
Annals of surgical oncology, vol 20, iss 8
Annals of Surgical Oncology
Annals of Surgical Oncology
BackgroundSentinel lymph node (SLN) surgery is used worldwide for staging breast cancer patients and helps limit axillary lymph node dissection. [(99m)Tc]Tilmanocept is a novel receptor-targeted radiopharmaceutical evaluated in 2 open-label, nonrando
Autor:
S. van Wieringen, Arjen J. Witkamp, H. J. G. D. van den Bongard, Helena M. Verkooijen, Monique G.G. Hobbelink, Emily L. Postma, I. H. M. Borel Rinkes
Publikováno v:
Breast cancer research and treatment, 134(2), 735-741. Springer New York
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment
Routine removal of the internal mammary chain (IMC) sentinel node in breast cancer patients remains a subject of discussion. The aim of this study was to determine the impact of routinely performed IMC sentinel node biopsy on the systemic and locoreg
Autor:
Erhan Berrak, Linda T. Vahdat, David Cox, Stefan Glück, Joyce O'Shaughnessy, Kristi McIntyre, James Song, Lee S. Schwartzberg
Publikováno v:
Breast Cancer Research and Treatment
Eribulin mesylate, a novel non-taxane microtubule dynamics inhibitor, is approved for treatment of metastatic breast cancer (MBC) in patients who have previously received at least 2 chemotherapeutic regimens for MBC that should have included an anthr
Autor:
Marcia Batista Salzgeber, T. T Benvenuti, João Carlos Sampaio Góes, Maria Lucia Hirata Katayama, Maria Aparecida Azevedo Koike Folgueira, Paulo Roberto Del Valle, Jane Haruko Lima Kaiano, Rosângela Portilho Costa Santos, Suzana Terumi Honda, Dirce Maria Carraro, Patricia Bortman Rozenchan, E. C. Lyra, Maria Mitzi Brentani, Cesar Torres, Helena Brentani
Publikováno v:
Tumour Biology
Our aim was to evaluate the interaction between breast cancer cells and nodal fibroblasts, by means of their gene expression profile. Fibroblast primary cultures were established from negative and positive lymph nodes from breast cancer patients and